Entity Common Stock, Shares Outstanding of ARROWHEAD PHARMACEUTICALS, INC. from Q2 2011 to Q4 2025

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
ARROWHEAD PHARMACEUTICALS, INC. quarterly Entity Common Stock, Shares Outstanding history and change rate from Q2 2011 to Q4 2025.
  • ARROWHEAD PHARMACEUTICALS, INC. Entity Common Stock, Shares Outstanding for the quarter ending 19 Nov 2025 was 136M shares, a 7.7% increase year-over-year.
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Change (%)

ARROWHEAD PHARMACEUTICALS, INC. Quarterly Entity Common Stock, Shares Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed
Q4 2025 136M +9.71M +7.7% 19 Nov 2025 10-K 25 Nov 2025
Q2 2025 138M +13.9M +11.2% 01 Aug 2025 10-Q 07 Aug 2025
Q1 2025 138M +13.9M +11.2% 01 May 2025 10-Q 12 May 2025
Q4 2024 126M +2.2M +1.78% 03 Feb 2025 10-Q 10 Feb 2025
Q2 2024 124M +17.1M +16% 01 Aug 2024 10-Q 08 Aug 2024
Q1 2024 124M +17.3M +16.2% 01 May 2024 10-Q 09 May 2024
Q4 2023 124M +15.6M +14.4% 31 Jan 2024 10-Q 06 Feb 2024
Q2 2023 107M +1.34M +1.27% 31 Jul 2023 10-Q 07 Aug 2023
Q1 2023 107M +1.16M +1.1% 24 Apr 2023 10-Q 02 May 2023
Q4 2022 108M +2.85M +2.7% 01 Feb 2023 10-Q 06 Feb 2023
Q2 2022 106M +1.59M +1.53% 28 Jul 2022 10-Q 04 Aug 2022
Q1 2022 106M +1.65M +1.59% 05 May 2022 10-Q 10 May 2022
Q4 2021 105M +1.67M +1.61% 31 Jan 2022 10-Q 02 Feb 2022
Q2 2021 104M +1.97M +1.92% 02 Aug 2021 10-Q 05 Aug 2021
Q1 2021 104M +2.31M +2.27% 30 Apr 2021 10-Q 04 May 2021
Q4 2020 104M +2.14M +2.1% 01 Feb 2021 10-Q 04 Feb 2021
Q2 2020 102M +6.99M +7.34% 27 Jul 2020 10-Q 05 Aug 2020
Q1 2020 102M +6.96M +7.34% 05 May 2020 10-Q 07 May 2020
Q4 2019 102M +9.43M +10.2% 03 Feb 2020 10-Q 05 Feb 2020
Q2 2019 95.3M +7.28M +8.27% 02 Aug 2019 10-Q 05 Aug 2019
Q1 2019 94.8M +7.24M +8.26% 06 May 2019 10-Q 08 May 2019
Q4 2018 92.2M +17.4M +23.2% 07 Dec 2018 10-K 11 Dec 2018
Q2 2018 88M +13.3M +17.7% 06 Aug 2018 10-Q 07 Aug 2018
Q1 2018 87.6M +12.8M +17.1% 07 May 2018 10-Q 08 May 2018
Q4 2017 74.8M +655K +0.88% 06 Dec 2017 10-K 12 Dec 2017
Q2 2017 74.8M +14M +23.1% 01 Aug 2017 10-Q 03 Aug 2017
Q1 2017 74.8M +14.8M +24.7% 02 May 2017 10-Q 03 May 2017
Q4 2016 74.2M +14.6M +24.5% 12 Dec 2016 10-K 14 Dec 2016
Q2 2016 60.8M +1.25M +2.1% 08 Aug 2016 10-Q 09 Aug 2016
Q1 2016 60M +462K +0.78% 09 May 2016 10-Q 10 May 2016
Q4 2015 59.6M +4.76M +8.69% 11 Dec 2015 10-K 14 Dec 2015
Q2 2015 59.5M +6.59M +12.5% 31 Jul 2015 10-Q 04 Aug 2015
Q1 2015 59.5M +7.63M +14.7% 08 May 2015 10-Q 11 May 2015
Q4 2014 54.8M +16.1M +41.6% 05 Feb 2015 10-Q 09 Feb 2015
Q2 2014 52.9M +21.4M +67.8% 11 Aug 2014 10-Q 12 Aug 2014
Q1 2014 51.9M +20.6M +65.7% 01 May 2014 10-Q 06 May 2014
Q4 2013 38.7M +23.1M +147% 16 Dec 2013 10-K 18 Dec 2013
Q2 2013 31.5M +20.2M +179% 05 Aug 2013 10-Q 07 Aug 2013
Q1 2013 31.3M +20.1M +179% 07 May 2013 10-Q 09 May 2013
Q4 2012 15.6M +5.12M +48.6% 21 Dec 2012 10-K 28 Dec 2012
Q2 2012 11.3M -60.5M -84.3% 03 Aug 2012 10-Q 13 Aug 2012
Q1 2012 11.2M 01 May 2012 10-Q 08 May 2012
Q4 2011 10.5M 15 Dec 2011 10-K 20 Dec 2011
Q2 2011 71.8M 01 Aug 2011 10-Q 08 Aug 2011
* An asterisk sign (*) next to the value indicates that the value is likely invalid.